News

In a recent study published in Life Metabolism, researchers at Fudan University report that even after stopping the anti-obesity drug tirzepatide, ...
Tirzepatide is a dual GIP/GLP-1 receptor agonist that has shown remarkable weight loss efficacy in global clinical trials. In China, the SURMOUNT-CN trial marked the first phase 3 study evaluating ...
The review that pooled the results of 11 studies has found that people started regaining weight two months after stopping the ...
Menopause can feel like one big balancing act. Between managing your hormone levels and symptoms like hot flashes, night ...
Undiscussed' side effect of weight loss drug Mounjaro revealed - The weight loss jab has come up in conversation for a bit of ...
Baseline BMI may play a significant role in improving exercise capacity, body weight and BP among patients with HF with ...
Experts reveal how Mounjaro actually works on your body after people took to social media complaining over 'hair loss' side effects.
Doctors around the world have been hailing "miracle" medications that make weight loss far easier, but new research suggests ...
While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...
Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...
Patients put on weight loss drugs like Ozempic and Wegovy may start regaining weight within weeks of discontinuing them, a ...
Patients prescribed drugs to help them lose weight may experience a rebound in weight gain after halting their prescription, finds a meta-analysis published in BMC Medicine.